HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cytokine storm after cessation of tocilizumab in a patient with refractory Takayasu arteritis.

AuthorsYoh Arita, Yoshikazu Nakaoka, Michio Otsuki, Kaori Higuchi, Takahiro Hashimoto-Kataoka, Taku Yasui, Takeshi Masaki, Tomohito Ohtani, Tadamitsu Kishimoto, Keiko Yamauchi-Takihara, Issei Komuro, Yasushi Sakata
JournalInternational journal of cardiology (Int J Cardiol) Vol. 187 Pg. 319-21 ( 2015) ISSN: 1874-1754 [Electronic] Netherlands
PMID25839635 (Publication Type: Case Reports, Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal, Humanized
  • Cytokines
  • tocilizumab
Topics
  • Adult
  • Antibodies, Monoclonal, Humanized (adverse effects)
  • Cytokines (blood)
  • Female
  • Humans
  • Recurrence
  • Substance Withdrawal Syndrome (blood)
  • Takayasu Arteritis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: